IndraLab

Statements


| 2

reach
"In addition, ABT-888 significantly inhibited NFkappaB (p65 and RelA) transcriptional activity in HER2+ but not HER2 negative breast cancer cells."

reach
"In addition, ABT-888 significantly inhibited NFkappaB (p65 and RelA) transcriptional activity in HER2+ but not HER2 negative breast cancer cells."